Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, TikTok and YouTube.

Health & Healthcare | Illumina

Illumina Leads the Way With Its Steps Against Cancer Campaign

Oct 31, 2024 10:00 AM ET

Illumina employees have been showing their commitment to early cancer detection and advancing research and treatment by getting involved in the company’s recently concluded Steps Against Cancer campaign.

Videos

Diversity & Inclusion | Illumina

Video: Increasing Genomic Capability in the United Arab Emirates

Nov 29, 2022 12:30 PM ET

Emirati scientists, clinicians, and dignitaries attended the opening of the Illumina Solutions Center in Dubai on November 8. The new state-of-the-art facility will expand genomics capabilities and build local expertise in genomics to advance and deliver precision medicine to patients at scale.

Responsible Business & Employee Engagement | Illumina

Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration

Oct 25, 2022 2:45 PM ET

Illumina CEO, Francis deSouza received the award for 3BL Media’s 2022 Responsible CEO of the Year: Innovation and ESG Integration.

Responsible Business & Employee Engagement | Illumina

In Our DNA: Suzanne Rohrback, Senior Staff Bioinformatics Scientist at Illumina

Oct 14, 2022 10:30 AM ET

As a scientist on Illumina’s Assay Research team in San Diego, Suzanne Rohrback works with colleagues to come up with new ways next-generation sequencing (NGS) can maximize insights from a sample—such as cells from a tumor or a tube of blood—extracting as much information about it as possible, as efficiently as possible.

Environment | Illumina

Minderoo Foundation and Illumina Commit $40M AUD To Apply Advanced Genomics to Marine Conservation

Aug 17, 2022 3:20 PM ET

Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions.

Innovation & Technology | Illumina

Home Genetic Testing Might Save a Few of Your Cat's Nine Lives

Aug 16, 2022 10:00 AM ET

At a Silicon Valley conference in 2016, Anna Skaya attended a talk by the founder of 23andMe, who joked that someone should start a company for cat genetics testing called “23andMeow.”